Medindia

X

Dr. Reddy's Laboratories Launches Nise D Spray for Quick, Targeted Pain Relief

by Dr. Trupti Shirole on  November 3, 2015 at 5:33 PM Drug News   - G J E 4
Strengthening its over the counter (OTC) portfolio, Pharma major Dr. Reddy's Laboratories on Monday, November 2, 2015, announced the launch of Nise D spray, which offers quick and targeted pain relief. The company said, "Through this product, Dr. Reddy's has further expanded its offerings in the therapeutic area of pain relief to consumers."
 Dr. Reddy's Laboratories Launches Nise D Spray for Quick, Targeted Pain Relief
Dr. Reddy's Laboratories Launches Nise D Spray for Quick, Targeted Pain Relief
Advertisement

In India, the market for pain relief products is approximately Rs. 1,700 crore. Pain relief sprays are growing 20 times faster than creams and gels. This indicates a trend of changing consumer preferences.

‘Nise has been providing effective relief to consumers by killing pain for several years. With a growing consumer preference for pain relief sprays, Dr. Reddy's has launched Nise D spray for quick and targeted pain relief.’
Advertisement
The formulation for Nise D Spray comprises of three key ingredients which get absorbed quicker, penetrate deep to reach the source of pain and reduce inflammation. Nise, as a brand has been providing effective relief to consumers by killing pain for several years.

Dr. Reddy's executive vice president and head, branded markets (India & Emerging countries) M.V. Ramana, said, "Nise D Spray marks our entry into the new segment and further boosts our OTC portfolio. Nise gel has made a remarkable headway into the market and looking at the market dynamics and consumer requirements, we expect Nise D Spray to have a great momentum and significant market share across regions."

Source: IANS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All